You are here: Industry Insights > medical products

News List

Tackling Substandard and Falsified Medical Products Shem Oirere
March 03, 2021
The outbreak and spread of COVID-19 could exacerbate Africa’s persistent challenge of production, importation and distribution of substandard and falsified medical products.
FDA Continues to Combat Fraudulent COVID-19 Medical Products americanpharmaceuticalreview
May 12, 2020
The U.S. Food and Drug Administration (FDA) is providing an update on the agency’s efforts to combat the extremely concerning actions by companies and individuals ...
UK and Europe tackle false COVID-19 medicinal products europeanpharmaceuticalreview
April 09, 2020
The MHRA and Council of Europe have both announced measures to prevent the spread of falsified or unlicensed COVID-19 medical products.
Handful pharma companies developing bulk of urgently needed medicines: Study biospectrumasia
November 22, 2018
“The fact that a handful of companies are carrying the bulk of the priority R&D load shows how fragile the situation is. A retreat by even one of these players would have a significant impact,”
Novo to buy 20% stake in UK’s ConvaTec pharmatimes
March 30, 2017
Novo A/S, the holding company for the Novo Group and fully owned subsidiary of the Novo Nordisk Foundation, has announced plans to acquire a 19.95 percent stake in UK medical...
Introducing IMEDS, a Public-Private Resource for Evidence Generation FDA
January 18, 2017
FDA has been working to establish a national resource for FDA-approved medical products that can be used by public and private-sector entities, including regulated industry, to conduct large scale evaluations of safety issues in an environment that is sec